Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase NA 1

Status

Completed 3

Sponsor Class

OTHER 2NETWORK 1

Study Type

Interventional 3

Sponsor

Cancer Type

Lymphoid 445Other hematologic neoplasm 419Myeloid 105Sarcoma 62Breast 62Plasma cell 39CNS 39Classical hematology 34Genitourinary 27Dermatologic 25Head & Neck 13Gynecologic 12Other neoplasm 5Thoracic 4Other solid neoplasm 4Gastrointestinal 4Tumor-Agnostic 3Other 3

Conditions

Neoplasms 2Carcinoma 1

Interventions

pembrolizumab 95Paclitaxel 86Gemcitabine 84Carboplatin 79Surveys and Questionnaires 72Docetaxel 61Bevacizumab 61Nivolumab 59Cisplatin 59Magnetic Resonance Spectroscopy 50Blood Specimen Collection 50Fluorouracil 48Capecitabine 47Radiotherapy 46Irinotecan 40Oxaliplatin 38Erlotinib Hydrochloride 38Biopsy 36atezolizumab 35Leucovorin 35Pemetrexed 34Standard of Care 32Cetuximab 32Specimen Handling 31Trastuzumab 30Radiosurgery 29Ipilimumab 28Cyclophosphamide 28Interviews as Topic 27olaparib 26

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Methotrexate × Tumor-Agnostic × Clear all
NCT02412670 2023-07-10

Chemotherapy Before Surgery in Treating Patients With High Grade Upper Urinary Tract Cancer

Eastern Cooperative Oncology Group

Phase 2 Completed
36 enrolled 14 charts
Tumor-Agnostic

Carcinoma

NCT02076997 2021-02-24

Individualized High Dose Methotrexate to Treat Cancer in Children Who Have a Significant Risk for Side Effects to Methotrexate

Baylor College of Medicine

Phase NA Completed
23 enrolled 11 charts
Tumor-Agnostic

Neoplasms

NCT01031420 2019-09-17

Dose Dense MVAC for Muscle Invasive Bladder Cancer

Fox Chase Cancer Center

Phase 2 Completed
54 enrolled 7 charts
Tumor-Agnostic

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡